ADVIL ALLERGY & CONGESTION RELIEF OTC
Generic Name and Formulations:
Ibuprofen 200mg, chlorpheniramine maleate 4mg, phenylephrine HCI 10mg; coated tabs.
Pfizer Consumer Healthcare
Indications for ADVIL ALLERGY & CONGESTION RELIEF:
Nasal congestion, headache, rhinorrhea, sinus pressure, fever, minor aches and pains.
Take with food. 1 tab every 4hrs; max 6 tabs/24hrs.
12yrs: not recommended.
Aspirin allergy. Immediately before or after cardiac surgery. During or within 14 days of MAOIs.
Increased risk of severe stomach bleeding (esp. ≥60yrs old). History of GI disorders (eg, heartburn, bleeding ulcers). Respiratory disorders (eg, emphysema, bronchitis). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Thyroid disease. Diabetes. Glaucoma. GI or urinary obstruction. Reevaluate if fever persists or worsens >3 days or pain/nasal congestion lasts >7 days. Elderly. Pregnancy (avoid during 3rd trimester). Nursing mothers.
Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Caution with diuretics. Avoid aspirin, phenylephrine- or chlorpheniramine-containing products, or other pain relievers, nasal decongestants, antihistamines. Alcohol, sedatives and tranquilizers may increase drowsiness. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAIDs, ≥3 alcoholic drinks/day, or prolonged use.
NSAID + antihistamine + sympathomimetic.
Drowsiness, nervousness, dizziness, insomnia, GI upset/bleed, symptoms of heart problems or stroke (eg, trouble breathing, feel faint, slurred speech), redness, swelling, allergic reactions; discontinue if occur.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Supported Employment vs Transitional Work in Veterans With PTSD
- Comparing Pharmacologic Treatments for Prevention of Rehospitalization in BP
- Preliminary Evidence Suggests Suicidal Thinking Is Self-Reinforcing
- Lower Fluoxetine Efficacy in Elderly Patients With Major Depressive Disorder
- Personal Health Information Found in Recycling